 

TCGA- CC- ASUC- 01A PR

II IIIIIIIIIIIII IIIII IIIIIIIIIIIIIII IIII II III
IHWMIIHM IIIIIIIIIIIIIIIIII III II IIIII “III IIIIIIIIIIII

UUID: 2184A680 F76C- 4953- 8107- 423E957852E1d } I

I IIIIII
III llIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIIIIIIII IIIIIIIII ,
Clinical Case Report Wgzjmi 3:6? a; M 5 up,
(For Collection of Cancerous TissueIm 8170/3

I» IACWMW 81765/3
Sate. MM WNOLS

 

 

IInformed Consenti (904) 44/3
I personally informed this patient that a specimen(s) would be collected to be used for research
purposes I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT

FORM with the patient and answered any questions the patient had The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution.

ﬂame of Physician or Study Coordinator I /Signatur: I Date

 

ICIInIcaI InformationI

GENERAL TION

Data of Riff}! ImmldlewI

a Single ﬂMarried

Ge’nder ' ’ n Divorced :3 Widow Blood Pressure Heart Rate
B Female ( ‘

 

 

HISTORY OF, PRESENT ILLNESS
Chief Complaints: A bﬁmg [mg/£2 (Muir )‘ jCk/QM )

 

 

Symptoms: \UJQCLIC’IKUSF Wolf [VI ICC)
I j .8

 

Clinical Findings:

 

Performance Scale (Karnofsky Score):
a 100 Asymptomatic CI 80~90 Symptomatic but Fully Ambulatory \d60~70 Symptomatic, in bed less than 50% of day
[:1 40—50 Symptomatic, in bed more than 50% of day, but mg bed ridden c: 20:30 Bed Ridden

 

 

 

CURRENT MEDICATIONS
Dose Route

 

PAST MEDICAL HISTORY
Disorder

 

 

 

 

CI Postmenopausal

 

OBIGYN HISTORY
Menopausal Status Date of ﬁrst Menses it of Pregnancies
D Pro-menopausal
a Peri-Menopausal Date of Last Menzies # of Live Births

 

 

 

 

Current Status
D YES NO

Current Status
YES O NO

Current Status
CI YES

Relative

Birth Control: 1:! Condom :3 Oral Contraceptive

C] Other:
"‘3

DIUD

 

SOCIAL HISTORY :

H

Alcohol

FAMILY MEDICAL HISTORY

I3 ﬂormone Replacement
Therapy:

m

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LAB DATA

Test Result I Date I Test Result Date
HIV :SINegative (:1 Positive: CEA D 1&ng :1 Positive:

Hep B @Negative D Positive: 1 I CA 15—3 [3 Negative D Positive:

Hep C B’Negative (3 Positive: / CA 19-9 D Negative £1 Positive:
AF? [3 Negative U Positive: PSA I13 Negative CI Positive:

Other: (:1 Negative CI Positive: Other: D Negative [3 Positive:

B/T Cell Markers:

 

 

DIAGNOSTIC STUDIES
Results
l IL " r"

CLINICAL DIAGNOSIS

\

Location of Involved l. Nodes Location of

T N c) M Stage:

 

{Treatment Informatiod

SURGICAL TMENT
Procedure
Tumor
Detailed

’\

Extension of

L Nodes
# of l.

Palpable, Non-Dlssected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Detailed Location

T' N M’)

NEOADJUVENT THERAPY or Molecular

Dose Route Date
To

To
To
To
To

 

Nodes

 

Pathology Form

 

ESpecimen Informationl

 

 

 

 

 

 

 

 

 

 

Collected by: _ .... Date: . .Time:__

Preserved by: _ Date: .Time:_
SPECIMEN TYPE (# of samples provided)

Frozen Parafﬁn Block Blood/Serum/Plasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
A .2 w?- 7 <9 2.
’ Time to LN2 Time to Formalin Time to LNZ
jg, min / 2 min min

 

 

 

 

 

 

PATHOLOGICAL DESCRIPTION

Tumor
Slze Extenslon of Tumor Distance to NAT

X ' X cm 6 cm

I. Nodes
#

Distant Metastasis

Notes:

 

Consolidated Pathology Diagnosis

Glandular cell

Cell

Cellular Differentiation: . :3 Well

Milntlc

   
  

Nuclear Grade:

 

 

 

 

57?? 01,717 D3615”; by 73" 1
{Final Pathology Reporli
Histological Diagnozﬂis:@ h (ye/42 £370? g ‘1 . g
6 ”>6 \ V "V f ‘ .
Comments: / /

 

 

 

g...— m

Director, Research Pathology

Cl epan
Fri ham ryTu uom riSu Dis
Mn»
HIPMDlscI "W
'n

 

